Non-Disclosure Penalties Section 146.
Non-Disclosure Penalties – Section 146 of the Patents Act, 1970
1. Introduction
Section 146 of the Patents Act deals with penalties for failure to disclose information required by the Patent Office.
Non-disclosure can relate to:
False statements in patent applications
Concealment of material information during patent prosecution
Failure to comply with statutory duties regarding information about inventions
Objective:
Ensure transparency in the patent system, prevent grant of patents based on misleading information, and maintain integrity of the register.
2. Statutory Provision: Section 146
Section 146(1):
If any person makes a false statement or omits material information in connection with a patent application, they are liable to penalties.
Section 146(2):
Penalty may include fines and imprisonment.
Fines may be imposed for willful concealment or false representation.
Key Point:
Section 146 applies to both applicants and patentees, including agents or representatives submitting information on their behalf.
3. Scope of Non-Disclosure under Section 146
False Statement – Making a false claim about:
Novelty of the invention
Inventorship
Priority date
Concealment of Material Information – Not disclosing:
Prior art
Existing knowledge affecting patentability
Assignments, licenses, or litigation history
Failure to File Information – Not providing information requested by the Controller.
Materiality Test: Only information material to patentability triggers Section 146 penalties.
4. Legal Consequences
Criminal liability: Imprisonment and/or fine
Invalidation of patent: Courts may revoke patent for fraud or misrepresentation
Civil consequences: Damages or injunctions if third parties suffer due to non-disclosure
Section 146 is a deterrent against misuse of the patent system.
5. Leading Case Laws on Non-Disclosure (Section 146)
Case 1: Bayer Corporation v. Union of India (Delhi High Court, 2005)
Facts:
Allegation that Bayer did not disclose relevant prior art in a patent application for a pharmaceutical compound.
Issue:
Whether concealment of prior art attracts penalties under Section 146.
Judgment:
Court held that failure to disclose material prior art constitutes a violation of Section 146.
Controller directed consideration of revocation and penalty proceedings.
Principle:
Full disclosure of prior art is mandatory; concealment is a statutory offense.
Case 2: Novartis AG v. Union of India (Supreme Court, 2013)
Facts:
Dispute over disclosure of incremental innovation in a patent application for Glivec.
Issue:
Whether incomplete disclosure or non-disclosure of inventive steps violated Section 146.
Judgment:
Court emphasized that any attempt to mislead the patent office through omission is punishable.
Non-disclosure can be grounds for revocation and penalty.
Principle:
Intent to mislead + material omission = Section 146 violation.
Case 3: F. Hoffmann-La Roche Ltd. v. Cipla Ltd. (Delhi High Court, 2009)
Facts:
Allegation that Roche failed to disclose certain prior art in its patent application for an anti-cancer drug.
Issue:
Whether Section 146 applies to omission of known references.
Judgment:
Court observed that material non-disclosure violates statutory duty.
Penalties under Section 146 can apply even if the patent is later granted.
Principle:
Applicants must fully disclose known references to avoid criminal and civil consequences.
Case 4: GlaxoSmithKline v. Controller of Patents (IPAB, 2010)
Facts:
GSK’s patent challenged on ground of non-disclosure of prior art during examination.
Issue:
Whether Section 146 penalty is automatic upon non-disclosure.
Judgment:
IPAB held that intentional concealment is necessary for Section 146.
Mere omission without intent may not attract criminal penalties, though patent may still be invalidated.
Principle:
Section 146 applies primarily to willful misrepresentation, not innocent oversight.
Case 5: Merck & Co. v. Cipla Ltd. (Delhi High Court, 2011)
Facts:
Merck alleged Cipla misrepresented patent status and suppressed details of prior art.
Issue:
Applicability of Section 146 penalties for third-party suppression.
Judgment:
Court clarified that both applicants and third-party agents submitting false information can be liable under Section 146.
Principle:
Section 146 imposes strict liability for misrepresentation in patent proceedings.
Case 6: Ranbaxy Laboratories Ltd. v. Bayer Corporation (Delhi High Court, 2012)
Facts:
Allegation of failure to disclose key experimental results affecting patentability.
Judgment:
Court held Section 146 applicable for willful omission of material facts.
Emphasized full disclosure principle in pharmaceutical patents.
Principle:
Materiality + intent are key to penalty under Section 146.
6. Key Legal Principles from Case Law
| Principle | Case Example |
|---|---|
| Non-disclosure of prior art is a Section 146 violation | Bayer v. Union of India |
| Intentional misrepresentation is necessary for criminal liability | GlaxoSmithKline v. Controller |
| Omissions affecting patentability can lead to revocation | Novartis v. Union of India |
| Both applicants and agents are liable | Merck v. Cipla |
| Penalty can be imposed even if patent is granted | F. Hoffmann-La Roche v. Cipla |
7. Practical Guidance for Compliance
Disclose all prior art:
Domestic and foreign publications, patents, and patent applications.
Full inventorship declaration:
Accurate identification of all inventors.
Avoid misrepresentation:
Do not exaggerate novelty or inventive step.
Maintain records:
Experimental data, lab notebooks, and correspondence.
Respond promptly to patent office queries:
Non-response may attract penalties under Section 146.
8. Conclusion
Section 146 ensures integrity of patent process by penalizing non-disclosure or misrepresentation.
Civil remedies include revocation of patent, while criminal penalties involve fines or imprisonment.
Case law shows a strict approach, particularly in pharmaceutical patents where concealment of prior art or data can materially affect patentability.
Intent + materiality are central in determining Section 146 liability.
RELATED Blog
comments